Pentazocine Hydrochloride and Naloxone Hydrochloride (GAVIS Pharmaceuticals, LLC)
Welcome to the PulseAid listing for the Pentazocine Hydrochloride and Naloxone Hydrochloride drug offered from GAVIS Pharmaceuticals, LLC. This Competitive Opioid Antagonists [MoA],Partial Opioid Agonist/Antagonist [EPC],Partial Opioid Agonists [MoA],Opioid Antagonist [EPC],Opioid Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | GAVIS Pharmaceuticals, LLC |
| NON-PROPRIETARY NAME: | Pentazocine Hydrochloride and Naloxone Hydrochloride |
| SUBSTANCE NAME: | PENTAZOCINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Competitive Opioid Antagonists [MoA],Partial Opioid Agonist/Antagonist [EPC],Partial Opioid Agonists [MoA],Opioid Antagonist [EPC],Opioid Antagonists [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2011-05-11 |
| END MARKETING DATE: | 0000-00-00 |
Pentazocine Hydrochloride and Naloxone Hydrochloride HUMAN PRESCRIPTION DRUG Details:
| Item Description | Pentazocine Hydrochloride and Naloxone Hydrochloride from GAVIS Pharmaceuticals, LLC |
| LABELER NAME: | GAVIS Pharmaceuticals, LLC |
| DEA SCHEDULE: | CIV
|
| ACTIVE STRENGTH: | 50; .5(mg/1; mg/1) |
| START MARKETING DATE: | 2011-05-11 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 43386-680_2b4af9bc-54d0-4367-b2d9-802f8805b99c |
| PRODUCT NDC: | 43386-680 |
| APPLICATION NUMBER: | ANDA075735 |
Other PENTAZOCINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
